Latest News

Novartis (SWX:NOVN) received European Commission approval for Itvisma, a one time gene replacement therapy for spinal muscular atrophy. The authorization covers a broad SMA population in the EU, including children, teens, and adults. Itvisma is described as the first and only single dose gene therapy in Europe that targets the genetic root cause of SMA across this age range. Novartis has built a pharmaceuticals business around complex conditions, and the approval of Itvisma reinforces that...

Universal Insurance Holdings stock has delivered very strong gains over the last five years, while the current valuation work suggests the shares still trade at a discount to an intrinsic value estimate built using an Excess Returns approach and supported by earnings multiples. Over 5 years, Universal Insurance Holdings has returned about 303.3%, which puts the recent share price firmly in the spotlight for anyone checking whether the story is already fully reflected. For the valuation, the...

Molina Healthcare, Inc. was recently dropped from several Russell growth and defensive indices but added to the Russell 2500 and Russell 2500 Value benchmarks, reflecting a reclassification in index exposure that occurred on 27 June 2026. This reshuffling highlights how index rebalancing can shift Molina’s investor base, emphasizing its value characteristics even as it faces headwinds from exchange risk adjustment transfers. We’ll now examine how Molina’s move into the Russell 2500 Value...

Those following along with EROAD Limited ( NZSE:ERD ) will no doubt be intrigued by the recent purchase of shares by...

The a2 Milk Company Limited ( NZSE:ATM ) stock is about to trade ex-dividend in 4 days. The ex-dividend date generally...

The Canadian market has been navigating a complex landscape, with recent cooling in energy prices and a slight economic contraction leading to expectations that the Bank of Canada will hold interest rates steady. In this context, investors may find opportunities in penny stocks, which, despite their historical connotations, remain relevant for those seeking affordable entry points into potentially high-growth companies. This article explores three such Canadian penny stocks that combine...

Global data is sending a mixed message, with growth pockets in places like Spain, Italy, India, China and Vietnam offset by softness in key services hubs such as Germany, the UK and Russia. For investors, that kind of uneven backdrop can make large, broad market bets feel blunt. This is where an AI Small Caps screener can help by surfacing under-the-radar companies that are applying machine learning, automation and data intelligence in focused ways. In this article you will see 3 of the best...

Regeneron Pharmaceuticals stock has delivered a 20.2% return over the past year, and with a high value score plus an undervalued read on market multiples, the current price invites a closer look at whether investors are still paying less than the business might be worth. Over the last 12 months, Regeneron Pharmaceuticals shares are up 20.2%, which puts recent gains firmly on the side of existing holders while raising the bar for new buyers. Regulatory momentum around cemdisiran for...

Cooling U.S. jobs data, softer expectations for Federal Reserve rate hikes, a weaker dollar and firmer gold prices are reshaping where risk and opportunity sit in the market. When rate expectations shift, capital often moves quickly between cash, bonds, stocks and real assets. This article looks at how that backdrop could affect specific companies tied closely to gold and precious metals, where revenues can be very sensitive to bullion prices and investor risk appetite. Below, you will find 3...

In June 2026, CA Immobilien Anlagen AG completed a €300 million senior unsecured green bond offering, issuing 3.500% bonds due July 7, 2029 at 99.303% of principal under Regulation S. This successful climate-focused financing strengthens the company’s funding profile while underlining its commitment to sustainable real estate investment and development. We’ll now examine how the completion of this senior unsecured green bond shapes CA Immobilien Anlagen’s investment narrative and capital...

Record highs in the Dow and S&P 500, a powerful chip stock rally, a stronger dollar and softer oil prices are reshaping where risk and opportunity may sit in large caps right now. To help make sense of it, this article focuses on three large cap blue chip stocks from our screener that appear especially exposed to these developments. These stocks may be affected in ways that could be either helpful or challenging, depending on your expectations and time frame. Each stock is backed by sizeable...

CARsgen Therapeutics Holdings announced that China’s National Medical Products Administration has approved satricabtagene autoleucel (satri-cel), an autologous Claudin18.2-targeted CAR T-cell therapy, for Claudin18.2-positive, HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma in patients who have failed at least two prior treatments. As the first CAR T-cell therapy approved globally for solid tumors, satri-cel could reshape treatment options in high-burden cancers like...

In late June 2026, Tenable Holdings, Inc. announced that its Tenable One Cloud Exposure platform secured FedRAMP High and Impact Level 5 authorization, allowing the company to support highly sensitive U.S. federal, defense and intelligence workloads. This milestone, combined with Tenable’s expanding AI collaborations, positions its exposure management platform as a contender for some of the most demanding government cybersecurity deployments. We’ll now examine how FedRAMP High and IL5...

Volkswagen stock is trading with a weak 5 year share price track record and a high overall value score, which raises a clear question for investors about whether current pessimism around its restructuring plans has pushed the valuation too far down or not far enough. Volkswagen shares have declined 41.8% over the past 5 years, which signals that long term holders have worn a heavy drawdown that now frames how attractive any apparent discount really is. The planned restructuring, including...

Smithfield Foods (SFD) drew fresh attention after recent trading saw the stock close at $24.58, with short term moves contrasting a decline over the past month and past 3 months. See our latest analysis for Smithfield Foods. Looking beyond the latest move to $24.58, Smithfield Foods has a 1 day share price return of 0.86% and a year to date share price return of 10.97%, while the 1 year total shareholder return is 5.13%. This suggests that near term momentum has picked up after weaker recent...

Consumer staples stocks are often seen as a potential anchor when inflation and living costs are under pressure, and Turkey’s latest data is a reminder of how quickly household budgets can be squeezed. With annual inflation at 32.11% and food inflation at 35.45%, as well as support measures like pension hikes on the table, investors may want to think carefully about which companies could see steadier demand, better pricing power, or relief from input and transport costs. This article walks...

Salesforce stock has fallen 38.4% over the past year, and both the intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and the current market multiples now point to the shares trading below what the underlying cash flows suggest. Over the last 12 months the share price decline of 38.4% has reset expectations and pushed Salesforce firmly into value territory for many investors. Recent upgrades that frame AI disruption fears as overdone may support sentiment, while ongoing...

D-Wave Quantum (QBTS) just secured more than $1.5 million in National Science Foundation funding for the ERASE project, underscoring federal interest in its dual-rail gate-model quantum effort in addition to its existing annealing systems. See our latest analysis for D-Wave Quantum. For investors watching the bigger picture, D-Wave Quantum’s 1-day share price decline of 4.13% and 30-day share price fall of 24.67% sit alongside a strong 90-day share price return of 57.33% and a very large...

SAP stock has fallen 44.5% over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to their assessed worth. Over the last 12 months, SAP has declined 44.5%, which means a lot of pessimism is already reflected in the share price. Recent moves to accelerate AI product development and deepen cloud partnerships can support long term cash flow expectations. At the same time, execution risk around...

Luckin Coffee (OTCPK:LKNC.Y) has opened new stores in New York City’s Grand Central Terminal and at 48th and 3rd, and has introduced self ordering kiosks that expand options beyond its mobile app. See our latest analysis for Luckin Coffee. The recent New York openings and kiosk rollout come as Luckin Coffee trades at US$31.21, with a 1 day share price return of 7.51% and a year to date share price return that is down 11.86%. At the same time, the 5 year total shareholder return of 158.36%...

Artificial intelligence is shaping everything from semiconductors and cloud infrastructure to everyday software tools, even as global growth signals remain mixed and inflation trends vary by region. While some economies show steady services activity and others face softer demand, companies tied directly to the ChatGPT and AI build out remain at the center of long term digital transformation. This AI Stocks screener focuses on businesses involved in chips, large language models, cloud and...

Marriott International (MAR) shares are back in focus after the company signed a global beverage agreement with The Coca-Cola Company, making Coca-Cola Marriott’s primary beverage partner across multiple hotel touchpoints. See our latest analysis for Marriott International. Set against this new Coca-Cola partnership and other recent agreements, including partnerships in Southeast Asia and ongoing brand activity, Marriott International’s share price is at US$372.95, with a 90 day share price...

First Interstate BancSystem has delivered a 103.8% return over the past three years, and both the intrinsic value estimate from the Excess Returns model and the earnings multiples currently point to the stock trading at a discount to their fair value read, even though the broader valuation checks are more mixed. A 103.8% three year return sets a high bar, so any perceived discount now matters for investors who care about both price and durability of that rerating. Insider selling and recent...

Morgan Stanley recently received conditional approval from the US Office of the Comptroller of the Currency to establish Morgan Stanley Digital Trust, a federally supervised national digital-asset trust bank focused on custody and related services for institutional clients. This approval marks a material step in bringing digital-asset custody into the traditional banking framework, potentially widening Morgan Stanley’s fee-based service offering in regulated crypto markets. Next, we’ll...